FMP
May 12, 2022 10:07 AM - Davit Kirakosyan
Globus Medical, Inc. (NYSE:GMED) reported its Q1 results, with EPS of $0.42 coming in worse than the consensus estimate of $0.47. Revenue was $230.5 million, compared to the consensus estimate of $234.17 million.
The EPS miss was driven by lower sales and weaker-than-expected margins. The company saw softness in Q1 mostly due to capital, but the pipeline has strengthened throughout Q2. The company posted its highest monthly U.S. spine sales in March and highest average daily sales in April.
The company reaffirmed its 2022 guidance as it builds out its product portfolio (NPIs in spine, trauma, imaging), drives robotic pull-through and continues record rep recruitment. For the full 2022-year, the company expects EPS of $2.10, compared to the consensus of $2.10, and revenue of $1.03 billion, compared to the consensus of $1.03 billion.
Sep 11, 2023 1:38 PM - Rajnish Katharotiya
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 1:49 PM - Rajnish Katharotiya
Price-to-Earnings ratio is a relative valuation tool. It is used by investors to find great companies at low prices. In this post, we will build a Python script to calculate Price Earnings Ratio for comparable companies. Photo by Skitterphoto on Pexels Price Earnings Ratio and Comparable Compa...
Oct 17, 2023 3:09 PM - Davit Kirakosyan
Shares of VMware (NYSE:VMW) witnessed a sharp drop of 12% intra-day today due to rising concerns about China's review of the company's significant sale deal to Broadcom. Consequently, Broadcom's shares also saw a dip of around 4%. Even though there aren’t any apparent problems with the proposed solu...